Objective: It has been suggested that the molecular identification of cancer cells in the circulation may be useful in predicting the presence of micrometastasis in several cancer types. The aim of the present study was therefore to assess the feasibility of CEA mRNA identification in blood for diagnosing and staging colorectal, gastric and pancreatic cancer. Methods: We studied 16 control subjects, 69 patients with colorectal (CRC), 30 with gastric (GC), 27 with pancreatic cancer (PC) and 8 with benign diseases of the pancreatobiliary tree. At diagnosis CEA mRNA was identified in peripheral blood by means of a RT-PCR procedure. Results: The specificity of this test in control subjects was 94%, and its sensitivity in identifying CRC, GC and PC were 34, 37 and 41%, respectively. False-positive findings were recorded in 25% patients with benign diseases. No association was found between CEA mRNA and stage in patients with GC or PC. In CRC patients, positive CEA mRNA findings were correlated with local spread (χ2 = 14.6, p < 0.01), lymph node (χ2 = 18.95, p < 0.001) and distant metastasis (χ2 = 11.3, p < 0.001). In these cases, CEA mRNA, but not CEA, was entered in stepwise discriminant analysis to classify the presence of lymph node metastasis. Conclusions: The molecular detection of micrometastasis in the blood by means of CEA mRNA identification is feasible for colorectal, but not for gastric or pancreatic cancer staging. Further studies are needed in order to define the clinical utility of this marker also in follow-up protocols.

Keywords:
Colorectal cancer, Gastric cancer, Pancreatic cancer, CEA, mRNA, Polymerase chain reaction
1.
Gordis L, Gold B: Epidemiology and etiology of pancreatic cancer; in Go VLW, Di Magno EP, Gardner JD, Lebenthal E, Reber HA, Scheele GA (eds): The Pancreas: Biology, Pathobiology and Disease. New York, Raven, 1993, pp 837–855.
2.
Liefers G-J, Cleton-Jansen A-M, van de Velde CJH, Hermans J, van Krieken JHJM, Cornelisse CJ, Tollenaar RAEM: Micrometastases and survival in stage II colorectal cancer. N Engl J Med 1998;339:223–228.
3.
Winawer SJ: Neoplasms of the stomach; in Wyngaarden JB, Smith LH, Bennett JC (eds): Cecil Textbook of Medicine. Philadelphia, Saunders, 1992, pp 667–671.
4.
Hermanek P: Prognostic factor research in oncology. J Clin Epidemiol 1999;52:371–374.
5.
Hermanek P: Tumors of the gastrointestinal tract and the pancreas: Histopathology, staging and prognosis. Anticancer Res 1999;19:2393–2396.
6.
Greenson JK, Isenhart CE, Rice R, Mojzisik C, Houchens D, Martin EW: Identification of occult micrometastases in pericolic lymph nodes of Dukes’ B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Cancer 1994;73:563–569.
7.
Mori M, Mimori K, Inoue H, Barnard GF, Tsuji K, Nanbara S, Ueo H, Akiyoshi T: Detection of cancer micrometastases in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res 1995;55:3417–3420.
8.
Mori M, Mimori K, Ueo H, Tsuji K, Shiraishi T, Barnard GF, Sugimachi K, Akiyoshi T: Clinical significance of molecular detection of carcinoma cells in lymph nodes and peripheral blood by reverse transcription-polymerase chain reaction in patients with gastrointestinal or breast carcinomas. J Clin Oncol 1998;16:128–132.
9.
Bostick PJ, Chatterjee S, Chi DD, Huynh KT, Giuliano AE, Cote R, Hoon DSB: Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. J Clin Oncol 1998;16:2632–2640.
10.
Futamura M, Takagi Y, Koumura H, Kida H, Tanemura H, Shimokawa K, Saji S: Spread of colorectal cancer micrometastases in regional lymph nodes by reverse transcriptase-polymerase chain reaction for carcinoembryonic antigen and cytokeratin 20. J Surg Oncol 1998;68:34–40.
11.
Kijima F, Natsugoe S, Takao S, Aridome K, Baba M, Yoshifumi M, Eizuru Y, Aikou T: Detection and clinical significance of lymph node micrometastasis determined by reverse transcription-polymerase chain reaction in patients with esophageal carcinoma. Oncology 2000;58:38–44.
12.
Gerhard M, Juhl H, Kalthoff H, Schreiber HW, Wagener C, Neumaier M: Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction. J Clin Oncol 1994;12:725–729.
13.
Burchill SA, Bradbury MF, Pittman K, Southgate J, Smith B, Selby P: Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction. Br J Cancer 1995;71:278–281.
14.
Funaki NO, Tanaka J, Kasamatsu T, Ohshio G, Hosotani R, Okino T, Imamura M: Identification of carcinoembryonic antigen mRNA in circulating peripheral blood of pancreatic carcinoma and gastric carcinoma patients. Life Sci 1996;59:2187–2199.
15.
Mori M, Mimori K, Ueo H, Karimine N, Barnard GF, Sugimachi K, Akiyoshi T: Molecular detection of circulating solid carcinoma cells in the peripheral blood: The concept of early systemic disease. Int J Cancer 1996;68:739–743.
16.
Jonas S, Windeatt S, O-Boateng A, Fordy C, Allen-Mersh TG: Identification of carcinoembryonic antigen-producing cells circulating in the blood of patients with colorectal carcinoma by reverse transcriptase polymerase chain reaction. Gut 1996;39:717–721.
17.
Soeth E, Röder C, Juhl H, Krüger U, Kremer B, Kalthoff H: The detection of disseminated tumor cells in bone marrow from colorectal cancer patients by a cytokeratin-20-specific nested reverse-transcriptase-polymerase-chain reaction is related to the stage of disease. Int J Cancer 1996;69:278–282.
18.
Soeth E, Vogel I, Röder C, Juhl H, Marxsen J, Krüger U, Henne-Bruns D, Kremer B, Kalthoff H: Comparative analysis of bone marrow and venous blood isolates from gastrointestinal cancer patients for the detection of disseminated tumor cells using reverse transcription PCR. Cancer Res 1997;57:3106–3110.
19.
Funaki NO, Tanaka J, Hosotani R, Kogire M, Suwa H, Imamura M: Quantitative analysis of carcinoembryonic antigen messenger RNA in peripheral venous blood and portal blood of patients with pancreatic ductal adenocarcinoma. Clin Cancer Res 1998;4:855–860.
20.
Castells A, Boix L, Bessa X, Gargallo L, Piqué JM: Detection of colonic cells in peripheral blood of colorectal cancer patients by means of reverse transcriptase and polymerase chain reaction. Br J Cancer 1998;78:1368–1372.
21.
Ueda T, Furui J, Komuta K, Yamaguchi J, Yamamoto M, Furukawa K, Kanematsu T: Detection of carcinoembryonic antigen mRNA in the mesenteric vein of patients with resectable colorectal cancer. Jpn J Surg 1998;28:701–706.
22.
Thorban S, Roder JD, Siewert JR: Detection of micrometastasis in bone marrow of pancreatic cancer patients. Ann Oncol 1999;10(suppl 4):S111–S113.
23.
Miyazono F, Takao S, Natsugoe S, Uchikura K, Kijima F, Aridome K, Shinchi H, Aikou T: Molecular detection of circulating cancer cells during surgery in patients with biliary-pancreatic cancer. Am J Surg 1999;177:475–479.
24.
Roder JD, Thorban S, Pantel K, Siewert JR: Micrometastases in bone marrow: Prognostic indicators for pancreatic cancer. World J Surg 1999;23:888–891.
25.
Ghossein RA, Rosai J: Polymerase chain reaction in the detection of micrometastases and circulating tumor cells. Cancer 1996;78:10–16.
26.
Pelkey TJ, Frierson HF, Bruns DE: Molecular and immunological detection of circulating tumor cells and micrometastases from solid tumors. Clin Chem 1996;42:1369–1381.
27.
Raj GV, Moreno JG, Gomella LG: Utilization of polymerase chain reaction technology in the detection of solid tumors. Cancer 1998;82:1419–1442.
28.
Nakanishi H, Kodera Y, Torii A, Hirai T, Yamamura Y, Kato T, Kito T, Tatematsu M: Detection of carcinoembryonic antigen-expressing tumor cells in peritoneal washes from patients with gastric carcinoma by polymerase chain reaction. Jpn J Cancer Res 1997;88:687–692.
29.
Nakanishi H, Kodera Y, Yamamura Y, Kuzuya K, Nakanishi T, Ezaki T, Tatematsu M: Molecular diagnostic detection of free cancer cells in the peritoneal cavity of patients with gastrointestinal and gynecological malignancies. Cancer Chemother Pharmacol 1999;43:S32–S36.
30.
Diamandis EP, Yu H: Prostate cancer, prostate-specific antigen and polymerase chain reaction. Clin Chem 1995;41:177–179.
31.
Johnson PWM, Burchill SA, Selby PJ: The molecular detection of circulating tumor cells. Br J Cancer 1995;72:268–276.
32.
Hermanek P, Hutter RVP, Sobin LH, Wittekind C: Classification of isolated tumor cells and micrometastasis. Cancer 1999;86:2668–2673.
33.
Plebani M, Basso D, Panozzo MP, Fogar P, Del Favero G, Naccarato R: Tumor markers in the diagnosis, monitoring and therapy of pancreatic cancer: State of the art. Int J Biol Marker 1995;10:189–199.
34.
Plebani M, De Paoli M, Basso D, Roveroni G, Giacomini A, Galeotti F, Corisini A: Serum tumor markers in colorectal cancer staging, grading and follow-up. J Surg Oncol 1996;62:239–244.
© 2000 S. Karger AG, Basel
2000
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.